Skip to main content
C1R: Prognostic Biomarker for Acute Myeloid Leukemia
DNMT3A: Epimutation in Acute Myeloid Leukemia
PRDM8: Biomarker for aplastic anemia and dyskeratosis congenita
Epigenetic-Aging-Signature for Blood
Epigenetic-Aging-Signature for Buccal Swaps
Quality control of cell cultures
Study design and bioinformatics
Get a quote
Welcome to cygenia
We provide service for your research
Biomarkers that are indicative for diseases, such as leukemia.
ANALYSIS OF BIOLOGICAL AGE
We have developed a blood test to estimate the state of aging.
QUALITY CONTROL OF STEM CELLS
Cygenia provides new methods for quality control of cell preparations.
PROGNOSIS OF ACUTE MYELOID LEUKEMIA
The overall survival can be estimated by DNA methylation in the gene of C1R.
ANALYSIS OF BIOLOGICAL AGE IN BLOOD
Cygenia provides a simple assay to estimate biological age from blood samples.
QUALITY CONTROL OF PLURIPOTENT CELLS
This assay allows robust classification of non-pluripotent and pluripotent cells.
Premature aging syndromes of blood can be diagnosed by DNA methylation in PRDM8.
ANALYSIS OF BUCCAL SWABS
The cellular composition and biological age can be estimated with buccal swabs.
MESENCHYMAL STEM CELLS
Reliable classification of human fibroblasts and human mesenchymal stem cells.
02/2016 - Epigenetic classification of mesenchymal stem cells
Cygenia provides new assay to discern human fibroblasts and mesenchymal stromal cells.
04/2016 - Biomarker for premature aging diseases
Cygenia provides new blood test that is indicative for premature aging diseases.
06/2016 - Signature for Buccal Swabs
Cygenia provides new assay to discern the composition of buccal epithelial cells and leukocytes in buccal swabs and sputum.